Issue 43: Pharma Digest

The Digest is for you, the valued members of our pharma community. Receive the latest market movements, breaking pharma news, business-critical whitepapers and content, and updates on our exclusive executive summits. Don’t forget to subscribe using the button above.

Let's get started.

?? Revolutionize Your Pharma Commercialization with Generative AI

Don't fall behind competitors! Join industry leaders from UBC, AbbVie, AstraZeneca, Merck, and IQVIA to explore how GenAI can:

? Streamline operations ? Enhance customer engagement ? Drive strategic decision-making

??? Nov 13, 10AM EST/3PM GMT ?? Live Webinar (On-demand available)

Learn from experts and stay ahead in the AI-driven pharma landscape.

Register now

#PharmaAI #GenerativeAI #LifeSciences

With disparities in health outcomes continuing to be felt acutely within specific populations, health equity strategies are of considerable importance.

With huge thanks to 805 global respondents who completed our survey and helped set out the qualitative research from our brand-new Health Equity Strategies Outlook Report,?it’s evident that pharmaceutical organizations and healthcare providers are attaching significant strategic importance to health equity strategies – albeit at different degrees.???

This report provides a detailed analysis, backed by both quantitative and qualitative research, of today’s health equity strategies and how organizations are responding to challenges they face.?Read now.

?? Our latest PharmaPulse episode features Sonny Shergill, VP, Commercial Digital Health at AstraZeneca, discussing the future of digital health and AI. ??? Listen now: https://bit.ly/4dscKIh to hear about AstraZeneca's ambitious growth plans and innovative digital strategies. ?? Don't forget to subscribe on Spotify: https://bit.ly/4dRxcmX #DigitalHealth #AI #Pharmaceuticals #Podcast #AstraZeneca

Top 5 pharma news to watch

1. US FDA lifts clinical hold on Novavax's combo COVID-flu shot (Reuters.com, Nov 11)
2. With US launch progressing, ARS inks another licensing deal for epinephrine spray Neffy worth up to $465M (Fierce Pharma, Nov 11)
3. AbbVie's closely watched schizophrenia drug fails two studies, shares slide (Reuters.com, Nov 11)
4. With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC (Biopharma Dive, Nov 7)
5. An RNAi renaissance is creating a new generation of startups (Pharma Voice, Nov 7)

Event spotlight

The pharmaceutical industry has reached a critical juncture, where science and innovation meet access issues, inefficiencies, and shifting customer expectations. It's time to decide: continue down a path that's not working or take a risk and innovate for the future.

To move forward, we must commit to a purpose-led, tech-enabled, and data-driven future. It's time to break the cycle of risk aversion and siloed thinking to deliver more value, more efficiently, to more stakeholders.

Join us at Reuters Events: Pharma 2025 in Barcelona, the industry's collaborative home for 23 years. Our 2025 agenda is designed to provide practical action and real-world strategies to map the course of your next 12 months. Be part of the change with 1000+ like-minded leaders and trusted partners. Are you championing change? Learn more!

Other upcoming events

Pharma USA 2025 (March 18-19, Philadelphia)

Thanks for reading! If you have any feedback or would like to see something included in our newsletter, get in touch with our team!

EU Team

Daisy Beale

Ziyanda Dludla

Suzy Wang

Emma Haslam

USA Team

Charlotte Bastiaanse

Noah Dixon

Jacob Byerley

Samuel Baddeley

See you next time!